Medable’s New Intelligent Automation Capabilities Cut Clinical Trial Technology Deployment Timelines By 50%
Medable announces new intelligent automation technology applied across its clinical trials platform to cut standard trial build timelines by at least half.
ACRP: Sparks, Signals, and Success: Bringing Dedication to Disruption
Mohammed Ali of Medable: “Reapplying learnings to spark change and achieve scalability”
“The COVID-19 pandemic provided new impetus for creativity in clinical research, following several decades with little major disruption,” says Mohammed Ali, Chief Domain Expert at Medable. “Now we need to persevere to build on this momentum and move forward, applying pandemic learnings to create sustainable approaches.”
12 questions with: Dr Michelle Longmire
What was your background prior to this role, and how did it prepare you for the work you do now? I learned a lot of the key qualities of being a CEO from team sports and my experience conducting research at Stanford. It was the perfect combination that directly applies to leading the team at Medable, with a strong focus on our mission to get effective therapies to patients faster, plus the relentless drive and working as a team to reach our goals.